|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/22 | |
| C07K 16/46 | |||
| A61K 39/395 | |||
| A61P 27/02 | |||
| C07K 16/28 |
| (11) | Patento numeris | 2992012 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14721806.9 |
| Europos patento paraiškos padavimo data | 2014-04-25 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-03-09 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-07-17 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2014/058417 |
| Data | 2014-04-25 |
| (87) | Numeris | WO 2014/177460 |
| Data | 2014-11-06 |
| (30) | Numeris | Data | Šalis |
| 13165744 | 2013-04-29 | EP | |
| 14151316 | 2014-01-15 | EP |
| (72) |
HARTMANN, Guido, DE
REGULA, Joerg Thomas, DE
RUETH, Matthias, DE
SCHAEFER, Wolfgang, DE
SCHLOTHAUER, Tilman, DE
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (54) | HUMAN FCRN-BINDING MODIFIED ANTIBODIES AND METHODS OF USE |
| HUMAN FCRN-BINDING MODIFIED ANTIBODIES AND METHODS OF USE |